AGIO:NASDAQ
Agios Pharmaceuticals Inc
$31.59
arrow_downward
-0.54%(-0.17) 1D
Nov 13, 4:00:01 PM GMT-5 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for AGIO...
Open
$31.64
High
$31.97
Low
$30.81
Mkt. cap
1.89B
Avg. vol.
1.25M
Volume
371.34K
52-wk high
$45.99
52-wk low
$22.24
EPS
-$6.32
Beta
0.66
Shares outstanding
59.81M
No. of employees
540
Open
$31.64
High
$31.97
Low
$30.81
Mkt. cap
1.89B
Avg. vol.
1.25M
Volume
371.34K
52-wk high
$45.99
52-wk low
$22.24
EPS
-$6.32
Beta
0.66
Shares outstanding
59.81M
No. of employees
540
News stories
From web sources and news partners
The Motley Fool
·
19 hours ago
Prediction: This Small-Cap Value ETF Will Beat the S&P 500 Over the Next 10 Years
Longbridge
·
1 day ago
[Weekly Recap] CTA Net Position Hits Extreme Low, Nasdaq…
Traders Union
·
30 minutes ago
Quinten Francois: Bitcoin and Ethereum underperform S&P 500 over five years
KuCoin
·
3 hours ago
AMD + Nvidia represent approximately 15% of the total S&P 50
Profile
Agios Pharmaceuticals Inc. is a publicly trading American pharmaceutical company pioneering therapies for genetically defined diseases, with a near-term focus on developing therapies for hemolytic anemias. The company was founded in 2008 by Lewis Cantley, Tak Mak and Craig Thompson. Agios is a Delaware corporation headquartered in Cambridge, Massachusetts. The company tendered an initial public offering in July 2013. Wikipedia
About Agios Pharmaceuticals Inc